View Item 

Show simple item record

A retrospective description of anesthetic medication dosing in overweight and obese children
dc.contributor.authorBurke, Constance N.en_US
dc.contributor.authorVoepel‐lewis, Terrien_US
dc.contributor.authorWagner, Deborahen_US
dc.contributor.authorLau, Irwinen_US
dc.contributor.authorBaldock, Andrewen_US
dc.contributor.authorMalviya, Shobhaen_US
dc.contributor.authorNafiu, Olubukolaen_US
dc.date.accessioned2014-08-06T16:49:58Z
dc.date.availableWITHHELD_13_MONTHSen_US
dc.date.available2014-08-06T16:49:58Z
dc.date.issued2014-08en_US
dc.identifier.citationBurke, Constance N.; Voepel‐lewis, Terri ; Wagner, Deborah; Lau, Irwin; Baldock, Andrew; Malviya, Shobha; Nafiu, Olubukola (2014). "A retrospective description of anesthetic medication dosing in overweight and obese children." Pediatric Anesthesia 24(8): 857-862.en_US
dc.identifier.issn1155-5645en_US
dc.identifier.issn1460-9592en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/108075
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherAnesthesiologyen_US
dc.subject.otherMedication Dosingen_US
dc.subject.otherOverweighten_US
dc.subject.otherObeseen_US
dc.subject.otherPediatricen_US
dc.titleA retrospective description of anesthetic medication dosing in overweight and obese childrenen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelSurgery and Anesthesiologyen_US
dc.subject.hlbsecondlevelPediatricsen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/108075/1/pan12396.pdf
dc.identifier.doi10.1111/pan.12396en_US
dc.identifier.sourcePediatric Anesthesiaen_US
dc.identifier.citedreferencePorter RM, Thrasher J, Krebs NF. Implementing a pediatric obesity care guideline in a freestanding children's hospital to improve child safety and hospital preparedness. J Pediatr Nurs 2012; 27: 707 – 714.en_US
dc.identifier.citedreferenceTobin JR, Shafer SL, Davis PJ. Pediatric research and scholarship: another Gordian knot? Anesth Analg 2006; 103: 43 – 48.en_US
dc.identifier.citedreferenceHan PY, Duffull SB, Kirkpatrick CM et al. Dosing in obesity: a simple solution to a big problem. Clin Pharmacol Ther 2007; 82: 505 – 508.en_US
dc.identifier.citedreferenceForse RA, Karam B, MacLean LD et al. Antibiotic prophylaxis for surgery in morbidly obese patients. Surgery 1989; 106: 750 – 756; discussion 6–7.en_US
dc.identifier.citedreferenceSpinler SA, Ou FS, Roe MT et al. Weight‐based dosing of enoxaparin in obese patients with non‐ST‐segment elevation acute coronary syndromes: results from the CRUSADE initiative. Pharmacotherapy 2009; 29: 631 – 638.en_US
dc.identifier.citedreferenceBaines D. Anaesthetic considerations for the obese child. Paediatr Respir Rev 2011; 12: 144 – 147.en_US
dc.identifier.citedreferenceDe Baerdemaeker LE, Mortier EP, Struys MM. Pharmacokinetics in obese patients. Contin Educ Anaesth Crit Care Pain 2004; 4: 152 – 155.en_US
dc.identifier.citedreferenceMortensen A, Lenz K, Abildstrom H et al. Anesthetizing the obese child. Pediatr Anesth 2011; 21: 623 – 629.en_US
dc.identifier.citedreferenceBentley JB, Borel JD, Vaughan RW et al. Weight, pseudocholinesterase activity, and succinylcholine requirement. Anesthesiology 1982; 57: 48 – 49.en_US
dc.identifier.citedreferenceLemmens HJ. Perioperative pharmacology in morbid obesity. Curr Opin Anaesthesiol 2010; 23: 485 – 491.en_US
dc.identifier.citedreferenceRose JB, Theroux MC, Katz MS. The potency of succinylcholine in obese adolescents. Anesth Analg 2000; 90: 576 – 578.en_US
dc.identifier.citedreferenceLeykin Y, Pellis T, Lucca M et al. The effects of cisatracurium on morbidly obese women. Anesth Analg 2004; 99: 1090 – 1094, table of contents.en_US
dc.identifier.citedreferencePhillips S, Edlbeck A, Kirby M et al. Ideal body weight in children. Nutr Clin Pract 2007; 22: 240 – 245.en_US
dc.identifier.citedreferencePeters AM, Snelling HL, Glass DM et al. Estimation of lean body mass in children. Br J Anaesth 2011; 106: 719 – 723.en_US
dc.identifier.citedreferenceGreen B, Duffull SB. What is the best size descriptor to use for pharmacokinetic studies in the obese? Br J Clin Pharmacol 2004; 58: 119 – 133.en_US
dc.identifier.citedreferenceCasati A, Putzu M. Anesthesia in the obese patient: pharmacokinetic considerations. J Clin Anesth 2005; 17: 134 – 145.en_US
dc.identifier.citedreferenceBrown KA, Laferriere A, Lakheeram I et al. Recurrent hypoxemia in children is associated with increased analgesic sensitivity to opiates. Anesthesiology 2006; 105: 665 – 669.en_US
dc.identifier.citedreferenceGross JB, Bachenberg KL, Benumof JL et al. Practice guidelines for the perioperative management of patients with obstructive sleep apnea: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. Anesthesiology 2006; 104: 1081 – 1093; quiz 117–8.en_US
dc.identifier.citedreferenceSchwengel LM. Perioperative management of children with obstructive sleep apnea. Anesth Analg 2009; 109: 60 – 75.en_US
dc.identifier.citedreferenceCheymol G. Effects of obesity on pharmacokinetics implications for drug therapy. Clin Pharmacokinet 2000; 39: 215 – 231.en_US
dc.identifier.citedreferenceShibutani K, Inchiosa MA Jr, Sawada K et al. Accuracy of pharmacokinetic models for predicting plasma fentanyl concentrations in lean and obese surgical patients: derivation of dosing weight (“pharmacokinetic mass”). Anesthesiology 2004; 101: 603 – 613.en_US
dc.identifier.citedreferenceHolford N. Dosing in children. Clin Pharmacol Ther 2010; 87: 367 – 370.en_US
dc.identifier.citedreferenceSamuels PJ. Anesthesia for adolescent bariatric surgery. Int Anesthesiol Clin 2006; 44: 17 – 31.en_US
dc.identifier.citedreferenceLemmens HJ, Brodsky JB. The dose of succinylcholine in morbid obesity. Anesth Analg 2006; 102: 438 – 442.en_US
dc.identifier.citedreferenceSuzuki T, Masaki G, Ogawa S. Neostigmine‐induced reversal of vecuronium in normal weight, overweight and obese female patients. Br J Anaesth 2006; 97: 160 – 163.en_US
dc.identifier.citedreferenceAnderson GD, Lynn AM. Optimizing pediatric dosing: a developmental pharmacologic approach. Pharmacotherapy 2009; 29: 680 – 690.en_US
dc.identifier.citedreferenceOgden CL, Carroll MD, Curtin LR et al. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 2006; 295: 1549 – 1555.en_US
dc.identifier.citedreferenceHedley AA, Ogden CL, Johnson CL et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA 2004; 291: 2847 – 2850.en_US
dc.identifier.citedreferencePan L, Blanck HM, Sherry B et al. Trends in the prevalence of extreme obesity among US preschool‐aged children living in low‐income families, 1998–2010. JAMA 2012; 308: 2563 – 2565.en_US
dc.identifier.citedreferenceNafiu OO, Ndao‐Brumlay KS, Bamgbade OA et al. Prevalence of overweight and obesity in a U.S. pediatric surgical population. J Natl Med Assoc 2007; 99: 46 – 48, 50–1.en_US
dc.identifier.citedreferenceSchirm E, Tobi H, de Jong‐van den Berg LT. Risk factors for unlicensed and off‐label drug use in children outside the hospital. Pediatrics 2003; 111: 291 – 295.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
pan12396.pdf
Size:
189.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.